The Challenges of the New EU Pharmaceutical Legislation

Know about the book -

The Challenges of the New EU Pharmaceutical Legislation is written by José Luis Valverde and published by IOS Press. It's available with International Standard Book Number or ISBN identification 1586035215 (ISBN 10) and 9781586035211 (ISBN 13).

In the domain of public policy on pharmaceuticals, protecting public health requires a dual strategy: robust regulation on the one hand and stimulation of competitiveness and innovation on the other. Regulation must be robust to ensure that only medicines meeting exact standards of safety, quality and efficacy are authorised for human and animal use. At the same time competitiveness and innovation must be stimulated. Without innovation in pharmaceuticals, the incurable diseases of today will remain incurable. Competitiveness drives innovation and innovation saves lives. Increased competitiveness of the pharmaceutical sector will not only better protect public health, but will also create high quality jobs and create growth. In this context the implementation of the G10 recommendations, particularly regarding the pricing and reimbursement of medicines by Member States, remains a considerable challenge.